Own opinion....10 Jan 2020 17:26
....for what its worth, is that this is a very special situation which could result in a massive increase in SP if all goes according to plan. My reasoning is:
1) This is a tiny microcap with virtually no open market. This levers price movements.
2) What is released by the co to the public will almost certainly not be the whole story. It is highly likely that at least one of their scientists will be working on at least one early stage antibody which will only be made public if /when at a more advanced stage.
3) The SP will always include a premium for likely buyout. In view of BVXP.s micro-sizing, a major pharma could bid from 'petty cash'.
4) Most UNimportant in these circumstances, you get a dividend from holding them.
5) Buffetology Fund own app 11%, so it fulfils that fund's criteria.
Apart from a lifetime of learning (and not always winning) I do not claim expertise, so please DYOR.